🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Fallopian Tube Carcinoma

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer NCT05538091Phase 21 site📍 Pittsburgh Ronald Buckanovich · Tests: Vismodegib, Atezolizumab Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites📍 Birmingham📍 Boston📍 Boston Regeneron Pharmaceuticals · Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Mind-body resilience training, Music therapy, Propranolol, Etodolac Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy NCT06024109n/a2 sites📍 Frankfurt am Main📍 Manresa Aesculap AG · Tests: Closure of the Vaginal Cuff after Total Hysterectomy Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer NCT07023484Phase 26 sites📍 Guangzhou📍 Shenzhen📍 Chai Wan The University of Hong Kong · Tests: KELIM, Carboplatin plus Paclitaxel, Interval debulking surgery GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion Registry Platform Ovarian and Endometrial Cancer NCT05129969n/a1 site📍 Multiple Locations iOMEDICO AG · Tests: Physician's choice according to patient's needs. MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site📍 Scottsdale Mayo Clinic · Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites📍 Phoenix📍 Tucson📍 Los Angeles Genmab · Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer NCT05009082Phase 365 sites📍 Amberg📍 Augsburg📍 Bad Homburg AGO Study Group · Tests: Carboplatin, Paclitaxel, Bevacizumab, Niraparib Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer NCT06787612Phase 256 sites📍 Birmingham📍 La Jolla📍 Los Angeles Regeneron Pharmaceuticals · Tests: Ubamatamab, Bevacizumab, Cemiplimab, Fianlimab, PLD Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites📍 Birmingham📍 Anchorage📍 Anchorage NRG Oncology · Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer NCT07851025Phase 3186 sites📍 Tampa📍 Baltimore📍 Billings AstraZeneca · Tests: Torvutatug samrotecan, Bevacizumab A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer NCT06161025Phase 2, Phase 3167 sites📍 Anchorage📍 New Haven📍 Coral Gables Daiichi Sankyo · Tests: R-DXd, Paclitaxel, Topotecan, PLD Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935Phase 319 sites📍 Miami📍 Weston📍 Boston M.D. Anderson Cancer Center · Tests: Chemotherapy, Laparotomy, Minimally Invasive Surgery, Quality-of-Life Assessment, Questionnaire Administration Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer NCT05200260Phase 29 sites📍 Foshan📍 Guangzhou📍 Hangzhou Shanghai Gynecologic Oncology Group · Tests: Primary debulking surgery, Neoadjuvant chemotherapy, PARP inhibitor, Bevacizumab Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma NCT06969833NA1 site📍 Lille Centre Oscar Lambret · Tests: Constitution of a biological collection, Assessment of Quality of Life and level of anxiety/depression Development and Management of Registry in Patients With Gynecologic Cancer in Korea NCT05912972n/a1 site📍 Seoul Asan Medical Center · Tests: Patient registry PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer NCT07472140Phase 2, Phase 31 site📍 Minsk N.N. Alexandrov National Cancer Centre · Tests: PARP inhibitor + Bevacizumab, PARP inhibitor Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies NCT05417594Phase 1, Phase 232 sites📍 La Jolla📍 Los Angeles📍 San Francisco AstraZeneca · Tests: AZD9574, Temozolomide (TMZ), [11C]AZ1419 3391, Trastuzumab Deruxtecan (T-DXd), Datopotamab Deruxtecan (Dato-DXd) Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer NCT04701645Phase 12 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Microdevice Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors NCT07586826Phase 21 site📍 Beijing Peking University People's Hospital · Tests: Romiplostim N01, All-trans retinoic acid A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04) NCT07776691Phase 311 sites📍 Washington D.C.📍 Burlington📍 Eugene Merck Sharp & Dohme LLC · Tests: R-DXd, Bevacizumab Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression NCT07546500Phase 359 sites📍 Phoenix📍 Antioch📍 Beverly Hills K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis … · Tests: Investigator's choice of Chemotherapy, Azenosertib Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer NCT05737303Phase 311 sites📍 Guangzhou📍 Ji'nan📍 Hangzhou Women's Hospital School Of Medicine Zhejiang University · Tests: nab-paclitaxel combined with carboplatin OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy NCT06466382NA10 sites📍 Baden📍 Basel📍 Sankt Gallen Swiss GO Trial Group · Tests: Treatment recommendation by molecular tumorboard (mTB) based on tumor profiling, Carboplatin / Paclitaxel Chemotherapy MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) NCT04111978Phase 353 sites📍 Graz📍 Graz📍 Innsbruck Swiss GO Trial Group · Tests: Letrozole 2.5mg, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy